Interactive NPV Analyzer

• Only service offering NPV (Net Present Value) Discounted Cash Flow models for over 3500 global products by Company and Therapy Area
• Interactive and fully transparent NPV calculation with multiple inputs at product level
• Edit key assumptions for any product NPV including annual and peak sales, patent expiry date, cost of capital and tax rate
• Model impact of  major events -  clinical trials, patent extension, litigation, etc on product valuation
• Product NPVs linked to share price 

Calendar of Events

• First fully comprehensive online calendar to track events impacting shareholder value
• Prioritizes events using product NPV as % of Market Cap
• Highlights potential event based investment opportunities
• Events included - clinical trial initiation and results, product filings and approvals (FDA, EU and Japan), patent and litigation, generic launches and financial results

EP Vantage

• Timely financial analysis of pivotal events put into context with EvaluatePharma market data
• Coverage includes regulatory & patent decisions, marketing approvals, licensing deals and M&A
• EventAnalyzer alert offers the most comprehensive daily round up of share price movements plus the story behind the news
• Advanced intelligence on potential market catalysts 

   Register for a Free Trial of EP Vantage